D. E. Shaw & Co., Inc. - USANA HEALTH SCIENCES INC ownership

USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 182 filers reported holding USANA HEALTH SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of USANA HEALTH SCIENCES INC
ValueSharesWeighting
Q3 2023$8,614,264
-14.4%
146,976
-8.0%
0.01%
-10.0%
Q2 2023$10,067,425
-6.8%
159,699
-7.0%
0.01%
-16.7%
Q1 2023$10,797,414
+14.6%
171,660
-3.1%
0.01%
+20.0%
Q4 2022$9,425,657
-1.8%
177,174
+3.4%
0.01%
-9.1%
Q3 2022$9,600,000
-25.3%
171,277
-3.5%
0.01%
-26.7%
Q2 2022$12,847,000
-6.7%
177,541
+2.5%
0.02%
+15.4%
Q1 2022$13,765,000
-25.0%
173,253
-4.5%
0.01%
-13.3%
Q4 2021$18,350,000
-5.6%
181,331
-14.0%
0.02%
-16.7%
Q3 2021$19,432,000
-11.2%
210,753
-1.3%
0.02%
-5.3%
Q2 2021$21,882,000
+0.8%
213,632
-4.0%
0.02%
-9.5%
Q1 2021$21,713,000
+45.8%
222,468
+15.2%
0.02%
+61.5%
Q4 2020$14,891,000
-4.5%
193,150
-8.8%
0.01%
-18.8%
Q3 2020$15,597,000
-20.3%
211,763
-20.5%
0.02%
-30.4%
Q2 2020$19,566,000
+10.3%
266,463
-13.2%
0.02%
-17.9%
Q1 2020$17,732,000
-39.6%
306,986
-17.9%
0.03%
-17.6%
Q4 2019$29,368,000
+25.3%
373,886
+9.1%
0.03%
+17.2%
Q3 2019$23,430,000
+8.7%
342,590
+26.2%
0.03%
+7.4%
Q2 2019$21,560,000
+7.1%
271,443
+13.1%
0.03%
+3.8%
Q1 2019$20,133,000
+50.6%
240,047
+111.3%
0.03%
+44.4%
Q4 2018$13,372,000
-3.0%
113,581
-0.7%
0.02%
+5.9%
Q3 2018$13,786,000
+50.2%
114,355
+43.7%
0.02%
+41.7%
Q2 2018$9,178,000
+42.3%
79,598
+6.0%
0.01%
+33.3%
Q1 2018$6,450,000
+26.5%
75,090
+9.0%
0.01%
+28.6%
Q4 2017$5,099,000
+38.4%
68,864
+7.8%
0.01%
+16.7%
Q3 2017$3,685,000
-6.1%
63,868
+4.3%
0.01%0.0%
Q2 2017$3,923,000
+16.4%
61,206
+4.6%
0.01%0.0%
Q1 2017$3,370,000
-25.0%
58,499
-20.3%
0.01%
-25.0%
Q4 2016$4,491,000
+8.8%
73,376
+145.9%
0.01%
+14.3%
Q3 2016$4,128,000
-26.9%
29,838
-41.1%
0.01%
-30.0%
Q2 2016$5,645,000
+525.8%
50,656
+582.1%
0.01%
+400.0%
Q1 2016$902,000
-76.6%
7,426
-75.4%
0.00%
-66.7%
Q4 2015$3,856,000
-47.9%
30,182
-45.3%
0.01%
-45.5%
Q3 2015$7,396,000
-46.6%
55,178
-45.6%
0.01%
-47.6%
Q2 2015$13,850,000
+29.9%
101,347
+5.6%
0.02%
+31.2%
Q1 2015$10,663,000
+40.0%
95,956
+29.2%
0.02%
+60.0%
Q4 2014$7,618,000
+2187.7%
74,260
+1540.7%
0.01%
Q3 2014$333,000
-91.1%
4,526
-90.6%
0.00%
-100.0%
Q2 2014$3,744,000
-14.2%
47,918
-17.3%
0.01%
-16.7%
Q1 2014$4,366,000
-9.4%
57,954
-9.1%
0.01%
-14.3%
Q4 2013$4,817,000
-22.5%
63,731
-11.0%
0.01%
-30.0%
Q3 2013$6,212,000
+22.5%
71,577
+2.1%
0.01%0.0%
Q2 2013$5,073,00070,0840.01%
Other shareholders
USANA HEALTH SCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
DENALI ADVISORS LLC 50,729$3,190,8541.33%
Cypress Capital, LLC 12,227$769,0780.25%
DGS Capital Management, LLC 6,835$429,9220.24%
PZENA INVESTMENT MANAGEMENT LLC 818,384$51,476,3540.22%
WINTON GROUP Ltd 26,950$1,695,1550.10%
Renaissance Technologies 1,211,797$76,2220.10%
Covestor Ltd 1,602$1010.09%
ACADIAN ASSET MANAGEMENT LLC 267,057$16,7780.07%
Ifrah Financial Services, Inc. 3,368$211,8470.07%
CAXTON ASSOCIATES LP 5,928$372,8710.06%
View complete list of USANA HEALTH SCIENCES INC shareholders